Clinical Trial Update: One-Year Results of GENOSS PCB Real-World Study in Femoropopliteal Artery Disease

View source ↗

Summary

One-year results from GENOSS PCB real-world study assessing a paclitaxel-coated balloon in peripheral artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• GENOSS PCB (paclitaxel-coated balloon)

Snippet

Sponsor: Genoss Co., Ltd. | Conditions: PTA (Percutaneous Transluminal Angioplasty), Femoropopliteal Artery Disease | Status: ENROLLING_BY_INVITATION